Medicine and Dentistry
Niacin
100%
Laropiprant
75%
Adverse Event
37%
Vascular Disease
37%
Incidence
37%
Combination Therapy
25%
Low Density Lipoprotein Cholesterol
25%
Adult
25%
Infection
12%
Myocardial Infarction
12%
Follow up
12%
Diagnosis
12%
Revascularization
12%
Apoplexy
12%
Musculoskeletal System
12%
Gastrointestinal System
12%
Aptitude
12%
Skin
12%
Nursing and Health Professions
Nicotinic Acid
100%
Placebo
50%
Patient
50%
Adverse Event
37%
Incidence
37%
Statin (Protein)
25%
Low Density Lipoprotein Cholesterol
25%
Combination Therapy
25%
Heart Infarction
12%
Confidence Interval
12%
Diabetes Mellitus
12%
Follow up
12%
Infection
12%
Rate Ratio
12%
Diagnosis
12%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
12%
Laboratory
12%
Death
12%
Revascularization
12%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
37%
Vascular Disease
37%
Incidence
37%
Low Density Lipoprotein Cholesterol
25%
Statin (Protein)
25%
Infection
12%
Heart Infarction
12%
Diabetes Mellitus
12%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
12%
Death
12%
Biochemistry, Genetics and Molecular Biology
Low Density Lipoprotein Cholesterol Level
37%
Statin
37%
Incidence
37%
Cholesterol
25%
Low-Density Lipoprotein
25%
High Density Lipoprotein Cholesterol Level
25%
Aptitude
12%
Immunology and Microbiology
Musculoskeletal System
12%